Le. Benjamin et al., Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal, J CLIN INV, 103(2), 1999, pp. 159-165
Features that distinguish tumor vasculatures from normal blood vessels are
sought to enable the destruction of preformed tumor vessels. We show that b
lood vessels in both a xenografted tumor and primary human tumors contain a
sizable fraction of immature blood vessels that have not yet recruited per
iendothelial cells. These immature vessels are selectively obliterated as a
consequence of vascular endothelial growth factor (VEGF) withdrawal. In a
xenografted glioma, the selective vulnerability of immature vessels to VEGF
loss was demonstrated by downregulating VEGF transgene expression using a
tetracycline-regulated expression system. In human prostate cancer, the con
stitutive production of VEGF by the glandular epithelium was suppressed as
a consequence of androgen-ablation therapy. VEGF loss led, in turn, to sele
ctive apoptosis of endothelial cells in vessels devoid of periendothelial c
ells. These results suggest that the unique dependence on VEGF of blood ves
sels lacking periendothelial cells can be exploited to reduce an existing t
umor vasculature.